|
1）日本肝移植研究会．肝移植症例登録報告．移植． 2014; 49: 261-74
|
|
|
|
2）日本臓器移植ネットワークホームページ. https://www.jotnw.or.jp/ (2015. 7. 1確認)
|
|
|
|
|
|
3）IRODaT Newsletter 2013. http://www.irodat.org/img/database/grafics/newsletter/IRODaT%20Newsletter%202013%20.pdf (2015. 7. 1確認)
|
|
|
|
|
|
4）Soyama A, Eguchi S. The current status and future perspectives of organ donation in Japan: learning from the systems in other countries. Surg Today. 2015 Jul 1. [Epub ahead of print]
|
|
|
|
|
|
5）市田隆文，玄田拓哉，平野克治．わが国における脳死肝移植医療の現状と問題点．肝臓．2015; 56: 79-87
|
|
|
|
|
6）Egawa H, Ueda Y, Kawagishi N, et al. Significance of pre-transplant abstinence on harmful alcohol relapse after liver transplantation for alcoholic cirrhosis in Japan. Hepatol Res. 2014; 44: 428-36
|
|
|
|
|
|
7）Pichlmayr R, Ringe B, Gubernatis G, et al. Transplantation of a donor liver to 2 recipients (splitting transplantation): A new method in the further development of segmental liver transplanta-tion. Langenbecks Arch Chir. 1988; 373: 127-30
|
|
|
|
|
8）Kim JS, Broering DC, Tustas RY, et al. Split liver transplantation: past, present and future. Pediatr Transplant. 2004; 8: 644-8
|
|
|
|
|
|
9）Broering DC, Mueller L, Ganschow R, et al. Is there still a need for living-related liver transplantation in children? Ann Surg. 2001; 234: 713-21
|
|
|
|
|
|
10）Mallik M, Callaghan CJ, Hope M, et al. Comparison of liver transplantation outcomes from adult split liver and circulatory death donors. Br J Surg. 2012; 99: 839-47
|
|
|
|
|
|
11）Decoster EL, Troisi R, Sainz-Barriga M, et al. Improved results for adult split liver transplantation with extended right lobe grafts: could we enhance its application? Transplant Proc. 2009; 41: 3403-6
|
|
|
|
|
|
12）Foster R, Zimmerman M, Trotter JF. Expanding donor options: marginal, living, and split donors. Clin Liver Dis. 2007; 11: 417-29
|
|
|
|
|
|
13）Maggi U, DeFeo TM, Andorno E, et al. Fifteen years and 382 extended right grafts from in situ split livers in a multicenter study: Are these still extended criteria liver grafts? Liver Transpl. 2015; 21: 500-11
|
|
|
|
|
|
14）Wan P, Li Q, Zhang J, Xia Q. Right lobe split liver transplantation versus whole liver transplantation in adult recipients: a systematic review and meta-analysis. Liver Transpl. 2015; 21: 928-43
|
|
|
|
|
|
15）Pipili C, Cholongitas E. Management of patients with hepatitis B and C before and after liver and kidney transplantation. World J Hepatol. 2014; 6: 315-25
|
|
|
|
|
|
16）Butler JC, Breiman RF, Campbell JF, et al. Pneumococcal polysaccharide vaccine efficacy. An evaluation of current recommendations. JAMA. 1993; 270: 1826-31
|
|
|
|
|
|
17）Hayashi N, Izumi N, Kumada H, et al. Simeprevir with peginterferon/ribavirin for treatment-naive hepatitis C genotype 1 patients in Japan: CONCERTO-1, a phase III trial. J Hepatol. 2014; 61: 219-27
|
|
|
|
|
|
18）Terrault NA. Hepatitis C therapy before and after liver transplantation. Liver Transpl. 2008; 14: S58-66
|
|
|
|
|
|
19）立波 忍，瀧 正志．HIV感染血友病におけるHCV感染について．日本エイズ学会誌．2005; 7: 7-10
|
|
|
|
|
|
20）Schiano TD, Kotler DP, Ferran E, et al. Hepatoportal sclerosis as a cause of noncirrhotic portal hypertension in patients with HIV. Am J Gastroenterol. 2007; 102: 2536-40
|
|
|
|
|
|
21）API net. エイズ予防ネット. 2010. http://api-net.jfap.or.jp/library/MeaRelDoc/nagasaki/index.html
|
|
|
|
|
|
22）Eguchi S, Takatsuki M, Soyama A, et al. Analysis of the hepatic functional reserve, portal hypertension, and prognosis of patients with human immunodeficiency virus/hepatitis C virus coinfection through contaminated blood products in Japan. Transplant Proc. 2014; 46: 736-8
|
|
|
|
|
|
23）高槻光寿，江口 晋，曽山明彦，他．血液製剤によるHIV-HCV重複感染者の予後―肝移植適応に関する考察―．肝臓．2012; 53: 586-90
|
|
|
|
|
|
24）Merchante N, Giron-Gonzalez JA, Gonzalez-Serrano M, et al. Survival and prognostic factors of HIV-infected patients with HCV-related end-stage liver disease. AIDS. 2006; 20: 49-57
|
|
|
|
|
|
25）Subramanian A, Sulkowski M, Barin B, et al. MELD score is an important predictor of pretransplantation mortality in HIV-infected liver transplant candidates. Gastroenterology. 2010; 138: 159-64
|
|
|
|
|
|
26）Ragni MV, Devera ME, Roland ME, et al. Liver transplant outcomes in HIV+ haemophilic men. Haemophilia. 2013; 19: 134-40
|
|
|
|
|
|
27）Taner T, Stegall MD, Heimbach JK. Antibody-mediated rejection in liver transplantation: current controversies and future directions. Liver Transpl. 2014; 20: 514-27
|
|
|
|
|
|
28）Shin M, Moon HH, Kim JM, et al. Significance of true-positive and false-positive pretransplantation lymphocytotoxic crossmatch in primary liver allograft outcomes. Transplantation. 2013; 95: 1410-7
|
|
|
|
|
|
29）OʼLeary JG, Kaneku H, Jennings LW, et al. Preformed class II donor-specific antibodies are associated with an increased risk of early rejection after liver transplantation. Liver Transpl. 2013; 19: 973-80
|
|
|
|
|